PARC: a phase I/II study evaluating the safety and activity of pegylated recombinant human arginase BCT-100 in relapsed/refractory cancers of children and young adults. Nicola Fenwick , Rebekah Weston , Keith Wheatley , Jodie Hodgson , Lynley Marshall , Martin Elliott , Guy Makin , Antony Ng , Bernadette Brennan , Stephen Lowis , Jenny Adamski , John Paul Kilday , Rachel Cox , Mike Gattens , Andrew Moore , Toby Trahair , Milind Ronghe , Martin Campbell , Helen Campbell , Molly W Williams , Maria Kirby , Natasha Van Eijkelenburg , Jennifer Keely , Ugo Scarpa , Victoria Stavrou , Livingstone Fultang , Sarah Booth , Paul Cheng , Carmela De Santo , Francis Mussai Frontiers in Oncology（2024）
关键词
arginase, arginine, pediatric, cancer, relapse
AI 理解论文
溯源树
样例
